Get started
Author

Zdenka E Segota

Observed names: Z. Segota, Z.E. Segota, Zdenka E. Segota, Zdenka Segota
OpenAlex ID: A5035594823
Phase II clinical activity and tolerability of the SMAC-mimetic birinapant (TL32711) plus irinotecan in irinotecan-relapsed/refractory metastatic colorectal cancer.
2013 · Neil N. Senzer, Patricia LoRusso, et al. · Journal of Clinical Oncology · 31
The Burden of Breast Cancer Predisposition Variants Across The Age Spectrum Among 10 000 Patients
2019 · Yanin Chavarri‐Guerra, Carolyn B. Hendricks, et al. · Journal of the American Geriatrics Society · 16
Phase I/II Study to Assess the Safety, Pharmacokinetics (PK) and Efficacy of Lorvotuzumab Mertansine (LM, IMGN901) in Combination with Carboplatin/Etoposide in Patients with Solid Tumors Including Small-Cell Lung Cancer (SCLC)
2012 · D.R. Spigel, J. Bendell, et al. · Annals of Oncology · 4
Unusual Brain Lesions Diagnosed From a Cerebrospinal Fluid Wet Preparation in a Patient With AIDS
2019 · Edgar L Bustamante, Margaret J Gorensek, et al. · Clinical Infectious Diseases · 2
PDF
A phase I dose-escalation study evaluating the effects of nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients (pts) with select relapsed or refractory hematologic malignancies.
2013 · Alexander M. Lesokhin, Martin Gutierrez, et al. · Journal of Clinical Oncology · 2
684 Results from ABILITY-1 monotherapy dose escalation and ongoing monotherapy expansion with MDNA11, a long-acting ‘beta-enhanced not-alpha’ IL-2 superkine, in patients with advanced solid tumors
2024 · Minh D To, Victoria Atkinson, et al. · Regular and Young Investigator Award Abstracts
EP16.02-003 Real World Experience and Feasibility of Tissue Informed CGP and ctDNA Testing in a Cohort of NSCLC Patients
2022 · G. Azzi, M. Krainock, et al. · Journal of Thoracic Oncology
PDF
Management of patients with adenocarcinoma
2018 · S. Willis, D. Maurente, et al. · HPB
PDF
Germline cancer susceptibility mutations in older women with breast cancer (BC).
2017 · Yanin Chavarri Guerra, Sharon Sand, et al. · Journal of Clinical Oncology
Works count: 9
Citation count: 55
H-index: 3
I10-index: 2
Year
Topic
Type